JP2010521514A5 - - Google Patents

Download PDF

Info

Publication number
JP2010521514A5
JP2010521514A5 JP2009553997A JP2009553997A JP2010521514A5 JP 2010521514 A5 JP2010521514 A5 JP 2010521514A5 JP 2009553997 A JP2009553997 A JP 2009553997A JP 2009553997 A JP2009553997 A JP 2009553997A JP 2010521514 A5 JP2010521514 A5 JP 2010521514A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
cyclopentyl
composition
acceptable excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009553997A
Other languages
English (en)
Japanese (ja)
Other versions
JP5087640B2 (ja
JP2010521514A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/052847 external-priority patent/WO2008113711A1/en
Publication of JP2010521514A publication Critical patent/JP2010521514A/ja
Publication of JP2010521514A5 publication Critical patent/JP2010521514A5/ja
Application granted granted Critical
Publication of JP5087640B2 publication Critical patent/JP5087640B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009553997A 2007-03-22 2008-03-11 Plk1阻害剤として有用な置換ピリミドジアゼピン Expired - Fee Related JP5087640B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91935807P 2007-03-22 2007-03-22
US60/919,358 2007-03-22
PCT/EP2008/052847 WO2008113711A1 (en) 2007-03-22 2008-03-11 Substituted pyrimidodiazepines useful as plk1 inhibitors

Publications (3)

Publication Number Publication Date
JP2010521514A JP2010521514A (ja) 2010-06-24
JP2010521514A5 true JP2010521514A5 (US07981874-20110719-C00313.png) 2011-04-21
JP5087640B2 JP5087640B2 (ja) 2012-12-05

Family

ID=39415299

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009553997A Expired - Fee Related JP5087640B2 (ja) 2007-03-22 2008-03-11 Plk1阻害剤として有用な置換ピリミドジアゼピン

Country Status (24)

Country Link
US (1) US7517873B2 (US07981874-20110719-C00313.png)
EP (1) EP2139892B1 (US07981874-20110719-C00313.png)
JP (1) JP5087640B2 (US07981874-20110719-C00313.png)
KR (1) KR101157848B1 (US07981874-20110719-C00313.png)
CN (2) CN102746175B (US07981874-20110719-C00313.png)
AR (1) AR065794A1 (US07981874-20110719-C00313.png)
AT (1) ATE524472T1 (US07981874-20110719-C00313.png)
AU (1) AU2008228303B2 (US07981874-20110719-C00313.png)
BR (1) BRPI0809088A2 (US07981874-20110719-C00313.png)
CA (1) CA2680757A1 (US07981874-20110719-C00313.png)
CL (1) CL2008000785A1 (US07981874-20110719-C00313.png)
CY (1) CY1112102T1 (US07981874-20110719-C00313.png)
DK (1) DK2139892T3 (US07981874-20110719-C00313.png)
ES (1) ES2371832T3 (US07981874-20110719-C00313.png)
HK (1) HK1139936A1 (US07981874-20110719-C00313.png)
HR (1) HRP20110807T1 (US07981874-20110719-C00313.png)
IL (1) IL200617A (US07981874-20110719-C00313.png)
MX (1) MX2009010034A (US07981874-20110719-C00313.png)
PE (1) PE20120495A1 (US07981874-20110719-C00313.png)
PL (1) PL2139892T3 (US07981874-20110719-C00313.png)
PT (1) PT2139892E (US07981874-20110719-C00313.png)
SI (1) SI2139892T1 (US07981874-20110719-C00313.png)
TW (1) TWI363629B (US07981874-20110719-C00313.png)
WO (1) WO2008113711A1 (US07981874-20110719-C00313.png)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2190849B1 (en) * 2007-08-15 2013-11-20 Vertex Pharmceuticals Incorporated 4-(9-(3,3-difluorocyclopentyl)-5,7,7-trimethyl-6-oxo-6,7,8,9-tetrahydro-5h-pyrimido[4,5-b[1,4]diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases
CN103122001A (zh) * 2007-09-25 2013-05-29 武田药品工业株式会社 Polo样激酶抑制剂
US8563542B2 (en) * 2007-09-28 2013-10-22 Cyclacel Limited Pyrimidine derivatives as protein kinase inhibitors
WO2009067547A1 (en) * 2007-11-19 2009-05-28 Takeda Pharmaceutical Company Limited Polo-like kinase inhibitors
TWI490214B (zh) 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為vap-1抑制劑之用途
WO2009153197A1 (en) * 2008-06-18 2009-12-23 F. Hoffmann-La Roche Ag Halo-substituted pyrimidodiazepines as plkl inhibitors
PT2364314E (pt) * 2008-12-09 2014-06-09 Gilead Sciences Inc Moduladores de recetores toll-like
US9266890B2 (en) 2009-01-06 2016-02-23 Dana-Farber Cancer Institute, Inc. Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
ES2604667T3 (es) 2009-06-17 2017-03-08 Vertex Pharmaceuticals Incorporated Inhibidores de la replicación de virus de influenza
NO2477987T3 (US07981874-20110719-C00313.png) 2009-09-14 2018-06-09
KR20140014110A (ko) 2010-12-16 2014-02-05 버텍스 파마슈티칼스 인코포레이티드 인플루엔자 바이러스 복제의 억제제
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
US9676792B2 (en) 2013-03-15 2017-06-13 Dana-Farber Cancer Institute, Inc. Pyrimido-diazepinone compounds and methods of treating disorders
BR112016001457A2 (pt) 2013-07-25 2017-08-29 Dana Farber Cancer Inst Inc Inibidores de fatores de transcrição e usos dos mesmos
TWI652014B (zh) * 2013-09-13 2019-03-01 美商艾佛艾姆希公司 雜環取代之雙環唑殺蟲劑
SG10201804021TA (en) 2013-11-13 2018-07-30 Vertex Pharma Methods of preparing inhibitors of influenza viruses replication
PL3068776T3 (pl) 2013-11-13 2019-10-31 Vertex Pharma Inhibitory replikacji wirusów grypy
WO2015117087A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
KR20160115953A (ko) 2014-01-31 2016-10-06 다나-파버 캔서 인스티튜트 인크. 디아미노피리미딘 벤젠술폰 유도체 및 그의 용도
NZ728072A (en) 2014-07-11 2018-06-29 Gilead Sciences Inc Modulators of toll-like receptors for the treatment of hiv
MX2017001756A (es) 2014-08-08 2017-05-30 Dana Farber Cancer Inst Inc Derivados de diazepano y sus usos.
CA2960436C (en) 2014-09-16 2021-01-05 Gilead Sciences, Inc. Solid forms of a toll-like receptor modulator
ES2845205T3 (es) 2014-09-16 2021-07-26 Gilead Sciences Inc Métodos para preparar moduladores de receptores tipo Toll
JP6704416B2 (ja) 2015-05-13 2020-06-03 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated インフルエンザウイルスの複製の阻害剤を調製する方法
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
AU2016276963C1 (en) 2015-06-12 2021-08-05 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
UA123946C2 (uk) 2015-09-11 2021-06-30 Дана-Фарбер Кенсер Інстітьют, Інк. Ацетамідтієнотриазолодіазепіни й шляхи їх застосування
RU2750164C2 (ru) 2015-09-11 2021-06-22 Дана-Фарбер Кэнсер Инститьют, Инк. Цианотиенотриазолодиазепины и пути их применения
WO2017091673A2 (en) 2015-11-25 2017-06-01 Dana-Farber Cancer Institute, Inc. Bivalent bromodomain inhibtors and uses thereof
AU2017248186B2 (en) * 2016-04-07 2021-10-21 Dana-Farber Cancer Institute, Inc. Pyrimido-diazepinone kinase scaffold compounds and methods of treating PI3K-mediated disorders
WO2021061894A1 (en) * 2019-09-27 2021-04-01 Dana-Farber Cancer Institute, Inc. Erk5 degraders as therapeutics in cancer and inflammatory diseases
EP3911654A4 (en) * 2020-03-27 2022-05-11 Uppthera COMPOUND INDUCING SELECTIVE DEGRADATION OF PLK1
WO2022145989A1 (ko) * 2020-12-31 2022-07-07 (주) 업테라 선택적 plk1 억제제로서의 피리미도디아제핀 유도체

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02002938A (es) * 1999-09-17 2004-12-06 Abbott Gmbh & Co Kg Inhibidores de cinasa como agentes agentes terapeuticos.
HUP0401293A3 (en) 2001-09-04 2008-03-28 Boehringer Ingelheim Pharma Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
WO2007095188A2 (en) * 2006-02-14 2007-08-23 Vertex Pharmaceuticals Incorporated Dihydrodiazepines useful as inhibitors of protein kinases
TW200808325A (en) * 2006-07-06 2008-02-16 Astrazeneca Ab Novel compounds

Similar Documents

Publication Publication Date Title
JP2010521514A5 (US07981874-20110719-C00313.png)
JP2014515013A5 (US07981874-20110719-C00313.png)
JP2010523692A5 (US07981874-20110719-C00313.png)
JP2015512931A5 (US07981874-20110719-C00313.png)
JP2006526031A5 (US07981874-20110719-C00313.png)
JP2010536766A5 (US07981874-20110719-C00313.png)
JP2008546809A5 (US07981874-20110719-C00313.png)
JP2008520662A5 (US07981874-20110719-C00313.png)
JP2013534248A5 (US07981874-20110719-C00313.png)
JP2011513196A5 (US07981874-20110719-C00313.png)
JP2009502743A5 (US07981874-20110719-C00313.png)
JP2012502037A5 (US07981874-20110719-C00313.png)
JP2009535462A5 (US07981874-20110719-C00313.png)
JP2008518890A5 (US07981874-20110719-C00313.png)
JP2010504343A5 (US07981874-20110719-C00313.png)
JP2010526777A5 (US07981874-20110719-C00313.png)
JP2011527667A5 (US07981874-20110719-C00313.png)
JP2010530897A5 (US07981874-20110719-C00313.png)
JP2009501198A5 (US07981874-20110719-C00313.png)
JP2014500861A5 (US07981874-20110719-C00313.png)
JP2007532575A5 (US07981874-20110719-C00313.png)
JP2010507589A5 (ja) Cb1受容体モジュレーターとしての1,5−ジフェニル−3−ピリジニルアミノ−1,5−ジヒドロピロリジン−2−オン
JP2009501704A5 (US07981874-20110719-C00313.png)
JP2010521516A5 (US07981874-20110719-C00313.png)
JP2010508310A5 (US07981874-20110719-C00313.png)